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2 T.S. and B.B. share senior authorship.The hypoxia-inducible factors HIF-1 and HIF-2 are primarily regulated via stabilization of their
respective a-subunits under hypoxic conditions. Previously, compensatory upregulation of one
HIF-a-subunit upon depletion of the other a-subunit was described, yet the underlying mechanism
remained elusive. Here we provide evidence that enhanced HIF-1a protein expression in HIF-2a
knockdown (k/d) cells neither results from elevated HIF-1a mRNA expression, nor from increased
HIF-1a protein stability. Instead, we identify enhanced HIF-1a translation as molecular mechanism.
Moreover, we found elevated levels of the RNA-binding protein HuR and provide evidence that HuR
is critical for the compensatory HIF-1a regulation in HIF-2a k/d cells.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction HIF-regulated gene expressionplays a central role in tumordevelop-The hypoxia-inducible factors (HIF)-1 and HIF-2 are heterodi-
meric transcription factors consisting of a constitutively expressed
b-subunit and an oxygen-labile a-subunit [1]. Under normoxic con-
ditionsHIF-1a andHIF-2a levels are hydroxylated at conserved pro-
lyl residues, provoking the binding of the vonHippel-Lindau protein
(pVHL) containing E3 ubiquitin ligase complex and subsequent pro-
teasomal degradation [2,3]. Nevertheless, low levels of HIF-2a have
recently been reported under normoxic conditions [4]. Under
hypoxic conditions, the respectiveprolyl hydroxylasesbecome inac-
tive which results in stabilization of the HIF-a subunits and initia-
tion of the transcription of speciﬁc hypoxia responsive genes [5].
In addition to protein stability regulation, alternative mechanisms
of HIF-1a regulation recently emerged. For example, increased
translation of HIF-1a in response to the hypoxia mimetic CoCl2
was shown to be controlled by the RNA-binding protein Human
antigen R (HuR) [6]. HuR is well established as a mRNA stability
and translation regulator of various targets involved in tumorigenic
processes such as proliferation, survival, angiogenesis, invasion and
metastasis [7]. In line, increased HuR expression has been reported
for multiple tumors and has been associated with a poor prognosis
[8,9]. Similarly, the HIFs are commonly upregulated in tumors andchemical Societies. Published by E
, human antigen R; GAPDH,
von Hippel-Lindau protein;
ein 3
e (T. Schmid).ment as HIF-targets are involved in angiogenesis, glycolysis, cell
growth,metastasis and anti-apoptosis [10,11]. Thus, theHIF-system
became a prominent target for the development of novel tumor
therapeutic agents, which aim at inhibiting the accumulation and/
or activity of either one of the HIFs [12–14]. Importantly, though,
we have shown in the past that depletion of one HIF-a subunit pro-
vokes a compensatory increase of the respective other a-subunit,
which in both cases provides a survival advantage for HepG2 cells
grown in tumor spheroids [15]. This reciprocal regulation and the
resulting survival beneﬁts might explain difﬁculties in current
tumor therapeutic approaches targeting the expression of one
HIF-a subunit only.
As mechanistic explanations for the compensatory regulation of
the HIF-a subunits are still missing, we aimed at understanding the
principles of the reciprocal increase of HIF-1a in HIF-2a depleted
cells and succeeded at identifying enhanced HIF-1a translation as
underlying mechanism. Furthermore, we provide evidence for the
involvement of the RNA-binding protein HuR in the compensatory
increase of the HIF-1a subunit.
2. Materials and methods
2.1. Materials
Chemicals were purchased from Sigma–Aldrich (Schnelldorf,
Germany), if not indicated otherwise. Antibodies (AB) were
obtained from the following sources: anti-HuR AB from Santa Cruz
Biotechnology (Heidelberg, Germany), anti-HIF-1a and anti-BNIP3
ABs from BD Biosciences (Heidelberg, Germany), anti-HIF-2a ABlsevier B.V. All rights reserved.
Fig. 1. Compensatory upregulation of HIF-1a protein in HIF-2a k/d cells. Wild type
control (Ctr.) and HIF-2a k/d HepG2 cells were incubated under normoxia (21% O2)
or hypoxia (1% O2) for 4 h. Expression of HIF-2a and HIF-1a proteins was monitored
by Western analysis. b-Actin served as loading control. Data are representative for
at least three independent experiments.
K. Schulz et al. / FEBS Letters 586 (2012) 1652–1657 1653from Abcam (Cambridge, United Kingdom), horseradish peroxidase
(HRP)-labeled anti-mouse and anti-rabbit secondary ABs from GE
Biosciences (Freiburg, Germany), IRDyes 680LT and 800CW
secondary ABs from Li-COR Biosciences GmbH (Bad Homburg,
Germany). Whatman nitrocellulose membrane was bought from
Schleicher & Schuell (Dassel, Germany) and ECL detection system
from GE Biosciences (Freiburg, Germany).
2.2. Cell culture
HepG2 monolayer cells were grown in minimal essential med-
ium (MEM) supplemented with 10% FBS, 2 mM L-glutamine, 100 U/
mL penicillin, 100 lg/mL streptomycin and 0.1 mM non-essential
amino acids. Medium of cells stably transduced with shRNAs addi-
tionally contained 2 lg/mL puromycin for selection purposes. Cells
were kept at 37 C in a humidiﬁed atmosphere with 5% CO2. For
hypoxic exposure, cells were incubated at 1% oxygen in a hypoxia
workstation (Ruskinn Technology, Leeds, United Kingdom). Med-
ium and supplements were purchased from PAA (Linz, Austria).
FBS came from Biochrom (Berlin, Germany).
2.3. Lentiviral transduction
The bacterial glycerol stocks containing HIF-2a and HuR shRNA
transfer vectors were delivered by Sigma–Aldrich. Lentivirus pro-
duction using HEK293T cells and subsequent transduction of
HepG2 cells were carried out following the protocols supplied by
the manufacturer. A non-target shRNA control clone (Ctr.) was ana-
lyzed to exclude transduction side effects.
2.4. Polysomal fractionation
HepG2 cells (1.25  107) were seeded in 15 cm dishes 1 day
prior to treatment of the cells. Subsequently, translation was ana-
lyzed by polysomal fractionation. Brieﬂy, 100 lg/mL cycloheximide
(CHX) was added to cells for the last 10 min of the incubations at
37 C. Then cells were scraped off in PBS/CHX (100 lg/mL) and
lysed in 750 lL polysome buffer [140 mM KCl, 20 mM Tris–HCl
(pH 8.0), 5 mM MgCl2, 0.5% NP40, 0.5 mg/mL heparin, 1 mM DTT,
100 U/mL RNasin (Promega, Mannheim, Germany), 100 lg/mL
CHX]. After pelleting, the cytoplasmic lysates were layered onto
11 mL 10–50% continuous sucrose gradients. The gradients were
centrifuged at 35,000 rpm for 2 h at 4 C without brake using a
SW40 rotor in a Beckman ultracentrifuge. Gradients were collected
in 1 mL fractions using a Biologic LP system (Biorad, München, Ger-
many). Absorbance wasmeasured at 254 nm. RNAwas precipitated
by 1/10 volume sodium acetate (3 M) and 1 volume isopropanol.
RNAwas further puriﬁed using the RNeasy MiniKit (Qiagen, Hilden,
Germany) according to the manufacturer’s manual. RNA was tran-
scribed using the Maxima First Strand cDNA synthesis kit from Fer-
mentas (St. Leon-Rot, Germany) and subsequently HIF-1a and
GAPDH mRNA levels were analyzed using realtime PCR with Abso-
lute qPCR SYBR Green Fluorescent mix (Thermo Fisher Scientiﬁc,
Bonn, Germany). Speciﬁc primers were individually designed (GAP-
DH-fwd: TGC ACC ACC AAC TGC TTA GC, GAPDH-rev: GGC ATG GAC
TGT GGT CAT GAG; HIF-1a-fwd: GCT GGC CCC AGC CGC TGG AG,
HIF-1a-rev: GAG TGC AGG GTC AGC ACT AC.
2.5. Western analysis
Cells from 6 cm conﬂuent cell culture dishes were lysed with
100 lL protein lysis buffer [6.65 M urea, 10% glycerol, 1% SDS,
10 mMTris, pH 7.4] and sonicated for 15  1 s. Hundredmicrogram
of protein/sample were separated on 10% SDS–polyacrylamide gels
and transferred onto nitrocellulose membranes. Proteins were
detected using speciﬁc antibodies and appropriate secondaryantibodies and visualized with an Odyssey infrared imaging system
(Li-COR Biosciences GmbH, Bad Homburg, Germany) or by en-
hanced chemiluminescence detection.
2.6. Transient transfection
HIF-2a k/d cells were transfected with 100 nm ON TARGETplus
SMARTpool siRNA speciﬁc for HuR using the Dharmafect 1 trans-
fection reagent (Thermo Fisher Scientiﬁc, Bonn, Germany) accord-
ing to the manufacturer’s protocol. Cells were analyzed 48 h after
transfection. The use of AllStars Negative Control siRNA (Ctr.siRNA)
(Qiagen, Hilden, Germany) was used to exclude unspeciﬁc effects.
2.7. Statistical analysis
Unless indicated otherwise, experiments were performed at
least three times. Data are presented as mean values ± SEM. Statis-
tical analysis was performed using Student’s t-test.
3. Results
3.1. Compensatory upregulation of HIF-1a in HIF-2a knockdown cells
Increased accumulation of HIF-1a in cells depleted of HIF-2a
has been reported previously [15–17]. Since we aimed at charac-
terizing the underlying molecular mechanism of this compensa-
tory phenotype, we established a stable knockdown (k/d) of HIF-
2a in HepG2 cells (HIF-2a k/d). Both, HIF-1a and HIF-2a protein
readily accumulated in response to hypoxic treatment (4 h, 1%
O2) in control cells (Fig. 1). Knockdown efﬁciency was proven by
the almost complete loss of HIF-2a protein expression in HIF-2a
k/d cells. Importantly, as predicted, HIF-1a protein accumulated
to higher levels in HIF-2a k/d cells than in control cells. Thus,
our hepatocellular cell culture model appeared appropriate to
study the compensatory increase of HIF-1a in HIF-2a deﬁcient
cells.
3.2. Posttranscriptional regulation of HIF-1a mRNA
To analyze the underlying mechanism of elevated HIF-1a pro-
tein levels in HIF-2a k/d cells, we assessed whether increased
HIF-1a accumulation is due to enhanced mRNA expression. There-
fore, we compared HIF-1a mRNA levels in HIF-2a k/d cells with
control cells but observed no differences in HIF-1a mRNA after
4 h of hypoxia (Fig. 2A). Of note, while GAPDH is a well-established
transcriptional target of HIF-1a in certain cell types, GAPDH mRNA
expression remained unaffected by the knockdown of HIF-2a and
the consequent increase in HIF-1a accumulation (Suppl. Fig. 1).
Thus, GAPDH was used to normalize HIF-1a mRNA data. HIF-1a
promoter reporter activity assays veriﬁed that HIF-1a transcription
Fig. 2. Neither increased HIF-1a expression, nor enhanced protein stability contribute to HIF-1a compensation in HIF-2a k/d cells. (A) Wild type control (Ctr.) or HIF-2a k/d
HepG2 cells were exposed to hypoxia (1% O2) for 4 h. HIF-1a and GAPDHmRNA expression levels were assessed by RT-qPCR. HIF-1amRNA levels were normalized to GAPDH
mRNA levels. Data represent means ± SEM (n > 3). (B) Ctr. and HIF-2a k/d cells were exposed to normoxia (21% O2) or hypoxia (1% O2) for 4 h in the presence or absence of the
transcription inhibitor Act D (2.5 lg/mL), which was added 5 min prior to hypoxia treatment. Protein expression of HIF-1a was followed by Western analysis. b-Actin served
as loading control. Data are representative for at least three independent experiments. (C) Ctr. and HIF-2a k/d cells were incubated under hypoxia (1% O2) for 4 h. Then the
translation inhibitor CHX (10 lM) was added for 15, 30 or 60 min. Protein expression of HIF-1a was followed by Western analysis. b-Actin served as loading control. Data are
representative for at least three independent experiments. (D) Half-life of HIF-1a protein was determined in Ctr. and HIF-2a k/d cells using the Odyssey infrared imaging
system for quantiﬁcation.
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these data ruled out changes in HIF-1a transcription as the under-
lying principle, we still aimed at connecting our ﬁndings to the
compensatory phenotype on the HIF-1a protein level. To this end
we pre-treated the cells with the transcription inhibitor actinomy-
cin D (Act D, 2.5 lg/mL) and followed HIF-1a protein expression. In
response to hypoxia (4 h, 1% O2) HIF-1a protein accumulation in
HIF-2a k/d cells remained elevated compared to control cells even
when transcription was blocked (Fig. 2B). Inhibition of transcrip-
tion of the hypoxia-responsive adrenomedullin (ADM), BNIP3 and
vascular endothelial growth factor (VEGF) under these conditions
veriﬁed that Act D efﬁciently blocked transcription at the used con-
centration (Suppl. Fig. 3). Of note, HIF-1a mRNA levels remained
stable in Ctr. and HIF-2a k/d cells in response to Act D, which indi-
cates that HIF-1a mRNA stability is not inﬂuenced by the HIF-2a
status (Suppl. Fig. 4). Taken together, compensatory HIF-1a regula-
tion in HIF-2a k/d cells does not result from changes in HIF-1a
mRNA expression, suggesting that other post-transcriptional
mechanisms are involved.
In a next set of experiments we determined whether increased
HIF-1a protein expression was due to enhanced protein stability.
To this end, control or HIF-2a k/d cells were exposed to hypoxia
for 4 h to allow for HIF-1a protein accumulation before de novo
protein synthesis was blocked for 15–60 min by adding cyclohex-
imide (CHX, 10 lM). HIF-1a protein accumulated rapidly and
was not more stable in HIF-2a k/d cells compared to Ctr. cells after
addition of CHX, yielding HIF-1a protein half-lives of 95 and
60 min for Ctr. and HIF-2a k/d cells, respectively (Fig. 2C and D).
Therefore, altered protein stability was excluded as underlying
mechanism. Taken together, we ruled out changes in mRNA
expression (transcription and mRNA stability) as well as protein
stability of HIF-1a to contribute to elevated protein levels in HIF-
2a k/d cells.
3.3. HIF-1a is translationally upregulated in HIF-2a k/d cells
To test whether elevated HIF-1a levels in HIF-2a k/d cells were
due to enhanced translation of HIF-1a, polysomal fractionationwas performed to follow the association of HIF-1a mRNA with
the translation machinery. For this purpose, cytoplasmic lysates
were generated and layered on continuous sucrose gradients
allowing for sedimentation of mRNAs according to their ribosome
occupancy after ultracentrifugation. Fractionation of individual
gradients yielded 10 fractions of equal volumes corresponding to
either monosomal, early polysomal or late polysomal portions
(Fig. 3A). The UV-proﬁles at 254 nm were similar for lysates from
control and HIF-2a k/d cells (Suppl. Fig. 5). Subsequently, RNA
was extracted from single fractions and the relative distribution
of HIF-1a and GAPDH mRNA of control and HIF-2a k/d cells across
the gradients was quantiﬁed by RT-qPCR. GAPDH was chosen as
housekeeping control as its expression did not change in HIF-2a
k/d cells as compared to Ctr. (Suppl. Fig. 1). Compared to control
cells, distribution of HIF-1a mRNA in HIF-2a k/d cells shifted from
the early polysomes (fractions 6–7) to the late polysomes (frac-
tions 8–10) (Fig. 3B). Speciﬁcally, the distribution of HIF-1a mRNA
in the pooled early polysome fractions (6–7) signiﬁcantly
decreased by 25% in HIF-2a k/d cells compared to control cells. In-
versely, HIF-1a mRNA distribution in the pooled late polysomes
(fractions 8–10) signiﬁcantly increased by 20% compared to control
cells. In contrast, the distribution of the housekeeping gene GAPDH
was not altered in HIF-2a depleted cells in comparison to control
cells (Fig. 3C). Based on these data, we propose that enhanced
HIF-1a translation contributes to the compensatory increase in
HIF-1a protein levels in HIF-2a k/d cells.
3.4. HuR is implicated in the compensatory induction of HIF-1a protein
As the RNA-binding protein HuR was previously shown to pro-
mote HIF-1a translation in response to hypoxia mimetic CoCl2 [6],
we determined HuR expression in HIF-2a k/d and control cells.
Interestingly, HuR protein levels were signiﬁcantly elevated in
HIF-2a k/d cells both under normoxic and hypoxic conditions
compared to control cells (Fig. 4A and Suppl. Table 1). To test
whether changes in HuR levels might alter HIF-1a protein expres-
sion, we efﬁciently knocked down HuR in HepG2 cells (HuR k/d)
using shRNAs (knockdown efﬁciency see Suppl. Fig. 6). Analysis
Fig. 3. Elevated HIF-1a protein levels in HIF-2a k/d cells result from enhanced HIF-
1a translation. To follow the association of HIF-1a mRNA with the translation
machinery, polysomal fractionation was performed. Therefore, cytoplasmic lysates
of wild type control (Ctr.) or HIF-2a k/d HepG2 cells incubated under hypoxia (1%
O2) for 4 h were separated via ultracentrifugation through continuous sucrose
gradients (10–50%). Resulting gradients were fractionated into 10 fractions of equal
volumes corresponding to monosomal, early polysomal or late polysomal portions.
The UV-proﬁles at 254 nm were followed during fractionation and appeared similar
for lysates from Ctr. and HIF-2a k/d cells. (A) An exemplary proﬁle of Ctr. lysates is
shown to illustrate which fraction corresponds to which distinct phase of the
proﬁle. (B and C) RNA was extracted from single fractions and the relative
distribution of HIF-1a and GAPDH mRNA of Ctr. (open squares, dashed lines) and
HIF-2a k/d cells (black squares, solid lines) across the gradients was determined by
RT-qPCR and is given relative to total HIF-1a and GAPDH mRNA isolated from all
fractions, respectively. The speciﬁc distribution of HIF-1a mRNA in pooled early
(fractions 6–7) and late polysomes (fractions 8–10) was quantiﬁed in HIF-2a k/d
cells relative to Ctr. cells. Results are shown as means ± SEM (n > 3, ⁄p < 0.05).
Fig. 4. HuR contributes to the compensatory upregulation of HIF-1a in HIF-2a k/d
cells. (A) Wild type control (Ctr.) or HIF-2a k/d HepG2 cells were incubated under
normoxia (21% O2) or hypoxia (1% O2) for 4 h. HIF-1a and HuR protein levels were
monitored by Western analysis. b-Actin served as loading control. (B) Empty vector
control (Ctr.) and HuR k/d HepG2 cells were exposed to normoxia (21% O2) or
hypoxia (1% O2) for 4 h. HIF-2a, HIF-1a and HuR protein expression was determined
by Western analysis. Tubulin served as loading control. (C) Wild type control (Ctr.)
and HIF-2a k/d HepG2 cells, either transfected with scrambled control siRNA (Ctr.
siRNA) or HuR speciﬁc siRNA (HuR siRNA) were exposed to hypoxia (1% O2) for 4 h.
HIF-1a, HuR and BNIP3 protein levels were assessed by Western analysis. b-Actin
served as loading control. Blots are representative for at least three independent
experiments.
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HIF-2a protein expression was markedly reduced in HuR k/d cells
compared to control cells (Fig. 4B). The HIF-2a protein level in HuRk/d cells was similar to that remaining in HIF-2a k/d cells. On the
other hand, HIF-1a protein accumulated to a similar degree in con-
trol and HuR k/d cells, which came as a surprise in the light of the
predicted compensatory upregulation of HIF-1a under conditions
of HIF-2a depletion. Based on these data we proposed that HuR
might be essential to facilitate the compensatory increase in HIF-
1a translation in HIF-2a depleted cells. To gain unequivocal
evidence for the role of HuR in the compensatory phenotype, we
knocked down HuR in HIF-2a depleted cells using siRNAs against
HuR. The transient knockdown was similarly effective in depleting
HuR protein levels as the stable shRNA mediated knockdown
(Fig. 4C). During hypoxia (4 h, 1% O2), HIF-1a protein level in
HIF-2a k/d cells depleted for HuR was similar to control cells, i.e.
HuR depletion attenuated the compensatory HIF-1a upregulation
in HIF-2a k/d cells compared to HIF-2a k/d cells or HIF-2a k/d /
Ctr. siRNA transfected cells (Fig. 4C and Suppl. Table 2). Impor-
tantly, the expression of the HIF-1 target BNIP3 followed the
reduced HIF-1a protein levels in HuR siRNA transfected HIF-2a
k/d cells, indicating that the HuR-mediated regulatory mechanism
1656 K. Schulz et al. / FEBS Letters 586 (2012) 1652–1657has an impact on HIF-1a dependent gene expression as well. We
therefore propose that knockdown of HIF-2a increases HuR
expression, which in turn contributes to elevated HIF-1a protein
accumulation.
4. Discussion
In the present study, we identify enhanced HIF-1a translation
as a mechanism to explain the compensatory upregulation of
HIF-1a protein in HIF-2a k/d HepG2 cells under hypoxic condi-
tions. We further provide evidence that the RNA-binding protein
HuR, which was previously shown to enhance HIF-1a translation,
is not only elevated in HIF-2a k/d cells, but appears critical for
the compensatory increase of HIF-1a protein in these cells and also
affects HIF-1a dependent gene expression programs in this setting.
Our observation of a compensatory increase of HIF-1a protein
in HIF-2a k/d cells is in accordance with recent reports proposing
reciprocal regulation of the HIF-a subunits in a broad spectrum
of cellular systems and tumor tissues [16–21]. Functionally, we
have previously shown that compensation results in a survival
advantage both in HIF-1a depleted tumor spheroids via enhanced
expression of anti-apoptotic Bcl-2 family members as well as in
HIF-2a depleted three-dimensional tumor cell cultures via ele-
vated HIF-1a dependent autophagy [15]. Others have shown that
the knockdown of HIF-1a in glioma cells increased the expression
of HIF-2a, thus favoring an angiogenic phenotype [22]. In line,
TGFb-induced VEGF expression in prostate cancer cells was en-
hanced by silencing HIF-1a or overexpression of HIF-2a, again
favoring angiogenesis [23].
With respect to the molecular mechanisms, our experiments
ruled out changes in HIF-1amRNA expression and protein stability
(Fig. 2). These observations are corroborated by others, describing
reciprocal regulation of the HIF-a subunits in cells defective for
the E3 ubiquitin ligase pVHL [16,17], thereby excluding altered
pVHL-dependent degradation of the a-subunits as mechanism
responsible for the compensatory phenotype. Instead, we noticed
enhanced translation of HIF-1a in HIF-2a k/d cells. Speciﬁcally,
HIF-1a mRNA shifted from early polysomes to later polysomes in
HIF-2a k/d cells (Fig. 3), which is indicative for increased ribosome
occupancy and consequently enhanced translation efﬁciency. Inter-
estingly, Galban et al. recently described increased HIF-1a transla-
tion in response to the hypoxia mimetic CoCl2 [6]. They identiﬁed
the RNA-binding protein HuR to promote HIF-1a translation under
these conditions. Along the same line, elevated HuR expression
was recently shown to increase translation of HIF-1a and the anti-
apoptotic protein XIAP1 [24,25]. Accordingly, we found elevated
HuR protein levels in HIF-2a k/d cells. Moreover, despite the almost
complete depletion of HIF-2a in HuR k/d cells, no compensatory
upregulation of HIF-1a was observed (Fig. 4B). While loss of HIF-
2a in HuR k/d cells corroborated the recent ﬁnding that HIF-2a is
a target of HuR [26], the lack of HIF-1a elevation was taken as an
indicator that HuR might play a role in the reciprocal regulation of
HIF-1a. This was further supported by the observation that deple-
tion of HuR in HIF-2a k/d cells attenuated HIF-1a compensation
and HIF-1a dependent induction of BNIP3 (Fig. 4D).
To our knowledge, this is the ﬁrst report exploring themechanism
underlying the reciprocal regulation of the HIF-a proteins. While the
HIFs are considered tobepromising targets for tumor therapies, there
are constraints in targeting single HIF-isoforms, potentially because
of their compensatory regulation. Thus, targeting factors such as
HuR that control both a-subunits and at the same time prevent
compensation might be a promising new therapeutic option.Acknowledgments
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